Found: 11
Select item for more details and to access through your institution.
Pre-clinical evaluation of antiproteases as potential candidates for HIV-1 pre-exposure prophylaxis.
- Published in:
- Frontiers in Reproductive Health, 2022, v. 4, p. 1, doi. 10.3389/frph.2022.998913
- By:
- Publication type:
- Article
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
- Published in:
- Microbiome, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40168-022-01247-6
- By:
- Publication type:
- Article
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
- Published in:
- Human Molecular Genetics, 2017, v. 26, n. 10, p. 1801, doi. 10.1093/hmg/ddx081
- By:
- Publication type:
- Article
Non-Lactobacillus-Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 8, p. 1372, doi. 10.1093/cid/ciac938
- By:
- Publication type:
- Article
Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa.
- Published in:
- American Journal of Reproductive Immunology, 2020, v. 83, n. 6, p. 1, doi. 10.1111/aji.13235
- By:
- Publication type:
- Article
The vaginal microbiome amplifies sex hormone‐associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption.
- Published in:
- American Journal of Reproductive Immunology, 2018, v. 80, n. 1, p. 1, doi. 10.1111/aji.12863
- By:
- Publication type:
- Article
Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 12, p. 1, doi. 10.1371/journal.ppat.1009097
- By:
- Publication type:
- Article
The neovaginal microbiome of transgender women post-gender reassignment surgery.
- Published in:
- Microbiome, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40168-020-00804-1
- By:
- Publication type:
- Article
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 3, p. 728, doi. 10.1016/j.molonc.2014.02.003
- By:
- Publication type:
- Article
Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Tolbutamide Controls Glucagon Release From Mouse Islets Differently Than Glucose.
- Published in:
- Diabetes, 2013, v. 62, n. 5, p. 1612, doi. 10.2337/db12-0347
- By:
- Publication type:
- Article